Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis.

@article{Kodali2016EarlyCA,
  title={Early clinical and echocardiographic outcomes after SAPIEN 3 transcatheter aortic valve replacement in inoperable, high-risk and intermediate-risk patients with aortic stenosis.},
  author={Susheel K. Kodali and Vinod H. Thourani and Jonathon M. White and Sukit Chris Malaisrie and Scott Lim and Kevin L Greason and Mathew Russell Williams and Mayra Guerrero and Andrew C. Eisenhauer and Samir R Kapadia and Dean J Kereiakes and Howard C Herrmann and Vasilis C. Babaliaros and Wilson Y. Szeto and Rebecca T. Hahn and Philippe Pibarot and Neil Weissman and Jonathon A. Leipsic and Philipp Blanke and Brian K. Whisenant and Rakesh M. Suri and Raj R. Makkar and Girma Minalu Ayele and Lars Georg Svensson and John G Webb and Michael J. Mack and Craig R Smith and M. Ben{\'i}tez Le{\'o}n},
  journal={European heart journal},
  year={2016},
  volume={37 28},
  pages={
          2252-62
        }
}
AIMS Based on randomized trials using first-generation devices, transcatheter aortic valve replacement (TAVR) is well established in the treatment of high-risk (HR) patients with severe aortic stenosis (AS). To date, there is a paucity of adjudicated, prospective data evaluating outcomes with newer generation devices and in lower risk patients. We report early outcomes of a large, multicentre registry of inoperable, HR, and intermediate-risk (IR) patients undergoing treatment with the next… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 71 CITATIONS

One year VARC-2-defined clinical outcomes after transcatheter aortic valve implantation with the SAPIEN 3

  • Clinical Research in Cardiology
  • 2019
VIEW 14 EXCERPTS
CITES METHODS, BACKGROUND & RESULTS
HIGHLY INFLUENCED

Multicenter Comparison of Novel Self-Expanding Versus Balloon-Expandable Transcatheter Heart Valves.

  • JACC. Cardiovascular interventions
  • 2017
VIEW 5 EXCERPTS
CITES BACKGROUND & RESULTS
HIGHLY INFLUENCED

Pros and cons of transcatheter aortic valve implantation (TAVI).

  • Annals of cardiothoracic surgery
  • 2017
VIEW 4 EXCERPTS
CITES BACKGROUND & METHODS
HIGHLY INFLUENCED

FILTER CITATIONS BY YEAR

2014
2019

CITATION STATISTICS

  • 4 Highly Influenced Citations

  • Averaged 22 Citations per year over the last 3 years

References

Publications referenced by this paper.
SHOWING 1-10 OF 26 REFERENCES

Transfemoral aortic valve replacement with the repositionable Lotus Valve System in high surgical risk patients: the REPRISE I study.

  • EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
  • 2014
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL

Learning curves for transfemoral transcatheter aortic valve replacement in the PARTNER-I trial: Technical performance.

  • Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions
  • 2016

30-day outcomes of intermediate-risk patients with the newgeneration balloon-expandable transcatheter heart valve via the transfemoral approach

A. Vahanian
  • 2015
VIEW 1 EXCERPT

Similar Papers

Loading similar papers…